United Therapeutics (UTHR) Tops Q3 EPS by 16c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $501.44 +0.70%
Revenue Growth %: -1.2%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
SUNB, CULP, KFY, More
Revenue Growth %: -1.2%
Financial Fact:
Interest expense: -500K
Today's EPS Names:
SUNB, CULP, KFY, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.50, $0.16 better than the analyst estimate of $3.34. Revenue for the quarter came in at $408.2 million versus the consensus estimate of $402.35 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- J.Jill (JILL) Tops Q2 EPS by 67c, Beats on Revenue; Offers Guidance
- Korn Ferry (KFY) Tops Q1 EPS by 7c, Beats on Revenue; Offers Q2 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
